Company: RGNT
Filing Date: 2025-05-05
Form Type: F-1/A
Source: 0001213900-25-039589
Chunk: 234

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-05
Form: F-1/A
Chunk 234
---
 of our Ordinary Shares in any jurisdiction where action for the purpose is
required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any
other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in
any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that country
or jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions
relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation
of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.

Australia

This prospectus is not a disclosure
document under Chapter 6D of the Australian Corporations Act, has not been lodged with the Australian Securities and Investments Commission
and does not purport to include the information required of a disclosure document under Chapter 6D of the Australian Corporations Act.
Accordingly, (i) the offer of the securities under this prospectus is only made to persons to whom it is lawful to offer the securities
without disclosure under Chapter 6D of the Australian Corporations Act under one or more exemptions set out in section 708 of the Australian
Corporations Act, (ii) this prospectus is made available in Australia only to those persons as set forth in clause (i) above, and (iii)
the offeree must be sent a notice stating in substance that by accepting this offer, the offeree represents that the offeree is such a
person as set forth in clause (i) above, and, unless permitted under the Australian Corporations Act, agrees not to sell or offer for
sale within Australia any of the securities sold to the offeree within 12 months after its transfer to the offeree under this prospectus.

<div align='center'>136</div>

Canada

The Ordinary Shares may be
sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument
45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National
Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the securities must be made
in accordance with